超声内镜引导下细针注射术治疗胰岛素瘤的中长期疗效分析  

Medium to long-term efficacy of endoscopic ultrasound-guided fine needle injection for insulinoma

作　　者：谭玉勇[1] 楚毅[1] 刘德良[1] 周雨迁[1] Tan Yuyong;Chu Yi;Liu Deliang;Zhou Yuqian(Department of Gastroenterology,The Second Xiangya Hospital of Central South University,Research Center of Digestive Diseases,Central South University,Changsha 410011,China)

机构地区：[1]中南大学湘雅二医院消化内科、中南大学消化病研究中心,长沙410011

出　　处：《中华消化内镜杂志》2023年第10期822-825,共4页Chinese Journal of Digestive Endoscopy

摘　　要：2017年6月—2021年5月在中南大学湘雅二医院消化内科共11例胰岛素瘤患者接受超声内镜引导下细针注射术(endoscopic ultrasound-guided fine needle injection,EUS-FNI)治疗。所有患者EUS-FNI治疗后中位随访45个月(12~60个月),6例患者仅1次治疗即可获得临床症状缓解,4例患者2次治疗症状缓解,仅1例患者需要2次以上治疗。以上结果初步显示EUS-FNI治疗胰岛素瘤可获得较好的中长期疗效。From June 2017 to May 2021,11 patients with insulinomas received endoscopic ultrasound-guided fine needle injection(EUS-FNI)at the Department of Gastroenterology,the Second Xiangya Hospital of Central South University.During a median follow-up of 45 months(12-60 months),symptoms of 6 patients were relieved with only 1 procedure of EUS-FNI,4 relieved with 2 procedures,and only 1 patient required more than 2 procedures.The results above preliminarily reveal that medium to long-term efficacy of EUS-FNI for insulinoma is good.

关 键 词：胰岛素瘤 超声内镜引导下细针注射术 无水乙醇 聚桂醇 

分 类 号：R735.9[医药卫生—肿瘤]